Skip to main content
Clinical Trials/NCT01842178
NCT01842178WithdrawnNot Applicable

Randomized Prospective Study of Endometrial Injury in In Vitro Fertilization Cycles With Oocyte Donation

Centro de Infertilidad y Reproducción Humana2 sites in 1 countryStarted: April 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
2
Primary Endpoint
biochemical pregnancy

Study Overview

Brief Summary

This study is designed to evaluate the potential benefit in pregnancy rates produced by an endometrial scratching made in an IVF cycle prior to embryo transfer in patients with donated oocytes.

Detailed Description

This is a randomized, comparative, prospective, double Blind study.

The First stage of this study consists of revising the patients medical records to identify possible candidates. Patients indicated are randomized into two groups: experimental and control. They are followed up to 12 week of pregnancy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
21 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Do IVF cycle with donor eggs
  • Will adjust to protocol for the study.
  • Have signed informed consent

Exclusion Criteria

  • Clinically significant systemic disease, hypothalamic or pituitary tumors
  • ovarian, uterine or breast cancer
  • hormonal abnormalities and / or medical , biochemistry, hematology pathology, which might interfere with gonadotropin treatment.
  • known positivity for human immunodeficiency virus (HIV), hepatitis C or B virus (HCV / HBV) of the candidate or her partner.
  • Uterine Factor(submucosal fibroids, intramural fibroids> 4 cm)
  • Hydrosalpinx
  • Patients receiving immune treatment
  • Positive Diagnosis Thrombophilia
  • preimplantation genetic diagnosis needed
  • In case of using marital sperm are excluded the following patients:Altered male karyotype, Altered Meiosis in testicular biopsy, Altered FISH, sperm Fragmentation> 45%
  • Pregnancy contraindication
  • Known allergy to preparations containing estrogens or any of its excipients.
  • Simultaneous participation in another clinical trial with medication.
  • Do not want or can not adjust to study protocol.

Outcomes

Primary Outcomes

biochemical pregnancy

Time Frame: 14-16 days post-follicular punction

Determination of human chorionic gonadotropin blood levels.

Secondary Outcomes

  • Clinical pregnancy(6 pregnancy weeks)

Investigators

Sponsor
Centro de Infertilidad y Reproducción Humana
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials